End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.34 CNY | -0.63% | -0.74% | +18.20% |
May. 13 | Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution | MT |
May. 02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
Sales 2024 * | 10.1B 1.4B | Sales 2025 * | 11.41B 1.58B | Capitalization | 25.4B 3.51B |
---|---|---|---|---|---|
Net income 2024 * | 1.12B 155M | Net income 2025 * | 1.42B 196M | EV / Sales 2024 * | 2.77 x |
Net Debt 2024 * | 2.54B 350M | Net Debt 2025 * | 2.31B 319M | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
17.8
x | Employees | 8,221 |
Yield 2024 * |
1.24% | Yield 2025 * |
1.67% | Free-Float | 56.08% |
1 day | -0.63% | ||
1 week | -0.74% | ||
Current month | +3.52% | ||
1 month | +16.77% | ||
3 months | +28.92% | ||
6 months | +10.59% | ||
Current year | +18.20% |
Managers | Title | Age | Since |
---|---|---|---|
Mei Zhang
DFI | Director of Finance/CFO | 48 | 08-05-31 |
Bao Hua Chen
PSD | President | 62 | 07-03-31 |
Si Jia Guo
BRD | Director/Board Member | 61 | 17-04-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bao Hua Chen
PSD | President | 62 | 07-03-31 |
Yong Hua Zhu
BRD | Director/Board Member | 59 | - |
Hu Gen Wang
CHM | Chairman | 75 | 10-04-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.57% | 2 M€ | -12.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 17.34 | -0.63% | 13,550,010 |
24-05-10 | 17.45 | -4.33% | 28,627,150 |
24-05-09 | 18.24 | +3.58% | 23,882,880 |
24-05-08 | 17.61 | -1.01% | 15,993,850 |
24-05-07 | 17.79 | +1.83% | 21,318,220 |
End-of-day quote Shanghai S.E., May 12, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.20% | 3.54B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 600521 Stock